List of Excipients in API selinexor
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing selinexor
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc | XPOVIO | selinexor | 72237-101 | CROSCARMELLOSE SODIUM | 2035-08-14 |
| Karyopharm Therapeutics Inc | XPOVIO | selinexor | 72237-101 | FD&C BLUE NO. 1 ALUMINUM LAKE | 2035-08-14 |
| Karyopharm Therapeutics Inc | XPOVIO | selinexor | 72237-101 | FD&C BLUE NO. 2--ALUMINUM LAKE | 2035-08-14 |
| Karyopharm Therapeutics Inc | XPOVIO | selinexor | 72237-101 | GLYCERYL MONOSTEARATE | 2035-08-14 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for selinexor
Excipient focus: CROSCARMELLOSE SODIUM
selinexor drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Karyopharm Therapeutics Inc | selinexor | 72237-101 |
| >Company | >Ingredient | >NDC |
selinexor drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
selinexor drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Karyopharm Therapeutics Inc | selinexor | 72237-101 |
| >Company | >Ingredient | >NDC |
selinexor drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
selinexor drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Karyopharm Therapeutics Inc | selinexor | 72237-101 |
| >Company | >Ingredient | >NDC |
selinexor drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOSTEARATE
selinexor drug variants containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Karyopharm Therapeutics Inc | selinexor | 72237-101 |
| >Company | >Ingredient | >NDC |
selinexor drug variants not containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
selinexor drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Karyopharm Therapeutics Inc | selinexor | 72237-101 |
| >Company | >Ingredient | >NDC |
selinexor drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
selinexor drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Karyopharm Therapeutics Inc | selinexor | 72237-101 |
| >Company | >Ingredient | >NDC |
selinexor drug variants not containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
selinexor drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Karyopharm Therapeutics Inc | selinexor | 72237-101 |
| >Company | >Ingredient | >NDC |
selinexor drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
selinexor drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Karyopharm Therapeutics Inc | selinexor | 72237-101 |
| >Company | >Ingredient | >NDC |
selinexor drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
selinexor drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Karyopharm Therapeutics Inc | selinexor | 72237-101 |
| >Company | >Ingredient | >NDC |
selinexor drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
selinexor drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Karyopharm Therapeutics Inc | selinexor | 72237-101 |
| >Company | >Ingredient | >NDC |
selinexor drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
selinexor drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Karyopharm Therapeutics Inc | selinexor | 72237-101 |
| >Company | >Ingredient | >NDC |
selinexor drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
selinexor drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Karyopharm Therapeutics Inc | selinexor | 72237-101 |
| >Company | >Ingredient | >NDC |
selinexor drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
selinexor drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Karyopharm Therapeutics Inc | selinexor | 72237-101 |
| >Company | >Ingredient | >NDC |
selinexor drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
selinexor drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Karyopharm Therapeutics Inc | selinexor | 72237-101 |
| >Company | >Ingredient | >NDC |
selinexor drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
selinexor drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Karyopharm Therapeutics Inc | selinexor | 72237-101 |
| >Company | >Ingredient | >NDC |
selinexor drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch